2020
DOI: 10.1016/j.ejps.2020.105465
|View full text |Cite
|
Sign up to set email alerts
|

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

Abstract: COVID-19, is a disease resulting from the SARS-CoV-2 global pandemic. Due to the current global emergency and the length of time required to develop specific antiviral agent(s) and a vaccine for SARS-CoV-2, the world health organization (WHO) adopted the strategy of repurposing existing medications to treat COVID-19. Iron oxide nanoparticles (IONPs) were previously approved by the US food and drug administration (FDA) for anemia treatment and studies have also demonstrated its antiviral activity in vitro. Ther… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
135
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 187 publications
(135 citation statements)
references
References 39 publications
0
135
0
Order By: Relevance
“…The safety of the nanotechnological products used in medicine is monitored and approved by the FDA [34,148]. There are already several cases of FDA-approved NP-based antivirals against different viruses, including influenza [145,149,150].…”
Section: Resultsmentioning
confidence: 99%
“…The safety of the nanotechnological products used in medicine is monitored and approved by the FDA [34,148]. There are already several cases of FDA-approved NP-based antivirals against different viruses, including influenza [145,149,150].…”
Section: Resultsmentioning
confidence: 99%
“…The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.10.20247130 doi: medRxiv preprint studies revealed that iron oxide nanoparticles interact efficiently with the SARS-CoV-2 spike binding proteins [22].…”
Section: Resultsmentioning
confidence: 99%
“…The study reported that both the iron oxide nanoparticles interacted with S-RBD. It was also revealed that a more stable compound was formed by Fe 3 O 4 with S-RBD [ 23 ].…”
Section: Metal Nanoparticles Affect Sars-cov-2 Targetsmentioning
confidence: 99%